R. Scott Wright

25.1k total citations · 13 hit papers
122 papers, 15.0k citations indexed

About

R. Scott Wright is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R. Scott Wright has authored 122 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cardiology and Cardiovascular Medicine, 52 papers in Surgery and 34 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R. Scott Wright's work include Lipoproteins and Cardiovascular Health (34 papers), Cardiac Imaging and Diagnostics (33 papers) and Acute Myocardial Infarction Research (30 papers). R. Scott Wright is often cited by papers focused on Lipoproteins and Cardiovascular Health (34 papers), Cardiac Imaging and Diagnostics (33 papers) and Acute Myocardial Infarction Research (30 papers). R. Scott Wright collaborates with scholars based in United States, Canada and United Kingdom. R. Scott Wright's co-authors include Lawrence A. Leiter, David Kallend, Kausik K. Ray, A. Michael Lincoff, Charles R. Bridges, Pierre Théroux, Nanette K. Wenger, Jeffrey L. Anderson, Eric D. Peterson and Francis M. Fesmire and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

R. Scott Wright

116 papers receiving 14.5k citations

Hit Papers

Effects of Dalcetrapib in Patients with a Recent Acute ... 2004 2026 2011 2018 2012 2007 2004 2020 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
    2012 1.5k citations Gregory G. Schwartz, David Kallend et al. New England Journal of Medicine profile →
  2. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    2007 1.4k citations R. Scott Wright et al. profile →
  3. Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction
    2004 1.0k citations Kevin A. Bybee, Tomáš Kára et al. profile →
  4. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
    2020 980 citations Kausik K. Ray, R. Scott Wright et al. New England Journal of Medicine profile →
  5. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
    2012 857 citations R. Scott Wright et al. profile →
  6. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
    2017 738 citations Kausik K. Ray, Ulf Landmesser et al. New England Journal of Medicine profile →
  7. 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    2013 704 citations R. Scott Wright et al. Journal of the American College of Cardiology profile →
  8. Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    2020 562 citations Frederick J. Raal, David Kallend et al. New England Journal of Medicine profile →
  9. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
    2011 382 citations R. Scott Wright et al. Journal of the American College of Cardiology profile →
  10. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
    2012 377 citations R. Scott Wright et al. Journal of the American College of Cardiology profile →
  11. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
    2023 193 citations Kausik K. Ray, Frank L.J. Visseren et al. The Lancet Diabetes & Endocrinology profile →
  12. Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
    2021 159 citations R. Scott Wright, Kausik K. Ray et al. Journal of the American College of Cardiology profile →
  13. Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
    2022 131 citations Kausik K. Ray, Frederick J. Raal et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Scott Wright United States 48 8.7k 6.6k 3.2k 2.0k 1.6k 122 15.0k
Felicita Andreotti Italy 45 10.1k 1.2× 5.8k 0.9× 2.6k 0.8× 1.9k 0.9× 1.1k 0.7× 179 15.2k
Christian Spaulding France 30 5.3k 0.6× 7.5k 1.1× 1.8k 0.6× 2.0k 1.0× 550 0.3× 107 11.7k
David D. Waters United States 70 10.7k 1.2× 9.1k 1.4× 5.3k 1.7× 5.8k 2.9× 1.6k 1.0× 337 22.3k
Allan M. Skene United Kingdom 27 10.2k 1.2× 6.6k 1.0× 1.3k 0.4× 2.2k 1.1× 891 0.6× 36 14.2k
Allen J. Taylor United States 60 7.6k 0.9× 5.1k 0.8× 5.4k 1.7× 2.1k 1.0× 821 0.5× 229 16.5k
José López‐Sendón Spain 56 10.0k 1.1× 4.1k 0.6× 1.7k 0.5× 1.9k 1.0× 734 0.5× 263 13.6k
Bariş Gencer Switzerland 32 6.5k 0.7× 3.7k 0.6× 2.2k 0.7× 1.3k 0.6× 553 0.3× 188 9.9k
John D. Rutherford United States 36 10.0k 1.1× 6.5k 1.0× 2.2k 0.7× 2.8k 1.4× 995 0.6× 111 16.7k
Steven E. Nissen United States 51 4.1k 0.5× 9.8k 1.5× 3.8k 1.2× 3.2k 1.6× 1.3k 0.8× 144 13.9k
Colin Baigent United Kingdom 51 8.9k 1.0× 11.0k 1.7× 1.4k 0.4× 4.7k 2.3× 1.3k 0.8× 136 22.6k

Countries citing papers authored by R. Scott Wright

Since Specialization
Citations

This map shows the geographic impact of R. Scott Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Scott Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Scott Wright more than expected).

Fields of papers citing papers by R. Scott Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Scott Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Scott Wright. The network helps show where R. Scott Wright may publish in the future.

Co-authorship network of co-authors of R. Scott Wright

This figure shows the co-authorship network connecting the top 25 collaborators of R. Scott Wright. A scholar is included among the top collaborators of R. Scott Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Scott Wright. R. Scott Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taub, Pam R., Edward Cantu, Anastasia Lesogor, et al.. (2025). Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD. Journal of the American College of Cardiology. 86(3). 196–208. 2 indexed citations
2.
Dragotakes, Quigly, Patrick W. Johnson, Rickey E. Carter, et al.. (2024). Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma. Proceedings of the National Academy of Sciences. 121(41). e2414957121–e2414957121. 4 indexed citations
3.
Colquhoun, David, R. Scott Wright, Kausik K. Ray, et al.. (2023). Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11). Heart Lung and Circulation. 32. S387–S387. 1 indexed citations
4.
Ray, Kausik K., Frank L.J. Visseren, Lawrence A. Leiter, et al.. (2023). Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial. The Lancet Diabetes & Endocrinology. 11(2). 109–119. 193 indexed citations breakdown →
5.
Ray, Kausik K., Frederick J. Raal, David Kallend, et al.. (2022). Inclisiran and cardiovascular events: a patient-level analysis of phase III trials. European Heart Journal. 44(2). 129–138. 131 indexed citations breakdown →
6.
Joyner, Michael J., Rickey E. Carter, DeLisa Fairweather, & R. Scott Wright. (2022). Convalescent plasma and COVID‐19: Time for a second—second look?. Transfusion Medicine. 33(1). 16–20. 5 indexed citations
7.
Casadevall, Arturo, Quigly Dragotakes, Patrick W. Johnson, et al.. (2021). Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality. eLife. 10. 37 indexed citations
8.
Ray, Kausik K., R. Scott Wright, David Kallend, et al.. (2020). Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. New England Journal of Medicine. 382(16). 1507–1519. 980 indexed citations breakdown →
9.
Andersen, Kylie J., Stephen A. Klassen, Kathryn F. Larson, et al.. (2020). Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors. Mayo Clinic Proceedings. 95(11). 2343–2349. 4 indexed citations
10.
Jentzer, Jacob C., Dennis H. Murphree, Brandon M. Wiley, et al.. (2018). Comparison of Mortality Risk Prediction Among Patients ≥70 Versus <70 Years of Age in a Cardiac Intensive Care Unit. The American Journal of Cardiology. 122(10). 1773–1778. 62 indexed citations
11.
Bennett, Courtney, R. Scott Wright, Jacob C. Jentzer, et al.. (2018). Severity of illness assessment with application of the APACHE IV predicted mortality and outcome trends analysis in an academic cardiac intensive care unit. Journal of Critical Care. 50. 242–246. 86 indexed citations
12.
Elesber, Ahmad A., Abhiram Prasad, Ryan J. Lennon, et al.. (2007). Four-Year Recurrence Rate and Prognosis of the Apical Ballooning Syndrome. Journal of the American College of Cardiology. 50(5). 448–452. 394 indexed citations
13.
Wright, R. Scott, et al.. (2006). Suspected Ventilator-Associated Pneumonia in Cardiac Patients Admitted to the Coronary Care Unit. Mayo Clinic Proceedings. 81(1). 32–35. 28 indexed citations
14.
Bybee, Kevin A., Arashk Motiei, Imran S. Syed, et al.. (2006). Electrocardiography cannot reliably differentiate transient left ventricular apical ballooning syndrome from anterior ST-segment elevation myocardial infarction. Journal of Electrocardiology. 40(1). 38.e1–38.e6. 77 indexed citations
15.
Nigam, Anil, R. Scott Wright, Thomas G. Allison, et al.. (2005). Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. International Journal of Cardiology. 110(2). 153–159. 81 indexed citations
16.
Wright, R. Scott, et al.. (2003). Effect of Diabetes on the Mortality Risk of Cardiogenic Shock in a Community-Based Population. Mayo Clinic Proceedings. 78(5). 561–566. 11 indexed citations
17.
Gami, Apoor S., R. Scott Wright, Karla V. Ballman, Stephen L. Kopecky, & Sharonne N. Hayes. (2003). Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus. The American Journal of Cardiology. 91(10). 1275–1277. 5 indexed citations
18.
Aviles, Ronnier J., R. Scott Wright, Furman S. McDonald, et al.. (2002). Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels. The American Journal of Cardiology. 90(8). 875–878. 18 indexed citations
19.
Brilakis, Emmanouil S., R. Scott Wright, Stephen L. Kopecky, et al.. (2001). Bundle branch block as a predictor of long-term survival after acute myocardial infarction. The American Journal of Cardiology. 88(3). 205–209. 52 indexed citations
20.
Brandt, Roland R., R. Scott Wright, Margaret M. Redfield, & John C. Burnett. (1993). Atrial natriuretic peptide in heart failure. Journal of the American College of Cardiology. 22(4). A86–A92. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felicita Andreotti Breakdown of academic impact, for papers by Christian Spaulding Breakdown of academic impact, for papers by David D. Waters Breakdown of academic impact, for papers by Allan M. Skene Breakdown of academic impact, for papers by Allen J. Taylor Breakdown of academic impact, for papers by José López‐Sendón Breakdown of academic impact, for papers by Bariş Gencer Breakdown of academic impact, for papers by John D. Rutherford Breakdown of academic impact, for papers by Steven E. Nissen Breakdown of academic impact, for papers by Colin Baigent
Rankless by CCL
2026